SAPPHIRE CLINICAL RESEARCH LTDActive
Key figures
Like most small UK companies, SAPPHIRE CLINICAL RESEARCH LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2020/21–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | — | 152,974 | 149,748 | 5,417 | 15,330 |
| Total assets | 168,999 | — | — | — | 15,330 |
| Total liabilities | 16,243 | 4,648 | 5,948 | 106,515 | 108,640 |
| Net assets / total equity | 151,207 | 148,150 | 143,290 | 146,309 | 155,235 |
| Average number of employees | 1 | 1 | 1 | 1 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: SAPPHIRE CLINICAL RESEARCH LTD
Company
SAPPHIRE CLINICAL RESEARCH LTD is a private limited company registered with Companies House under company number 08872774. It was incorporated on 3 Feb 2014. Its status is active. The registered office is in Olney (MK46). Its nature of business (SIC 2007) is management of real estate on a fee or contract basis (68320).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were £155,235, up 6.1% on the previous year. Cash at bank and in hand was £15,330. Total assets were £15,330 and total liabilities £108,640. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2024/25).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 29 Sep 2026.